Evidence map›Paper›PMID 20148179›Full record

ArticleSubstance abuse : research and treatment2008

Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Geeta Sharma, Sukumar Vijayaraghavan

Open access · greenAbstract read
In one paragraph

Article in Substance abuse : research and treatment, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Geeta SharmaDepartment of Physiology and Biophysics and the Neuroscience Program, University of Colorado, Denver, School of Medicine Aurora CO 80045.
Sukumar Vijayaraghavan
University of Colorado Denver · US

Funding

Cholinergic Modulation of OlfactionR01DC008855 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI VIJAYARAGHAVAN, SUKUMAR · 2007 to 2018
$3.2M
Nicotinic Signaling in the BrainR01DA010266 · NIDA · UNIVERSITY OF COLORADO DENVER · PI VIJAYARAGHAVAN, SUKUMAR · 1998 to 2012
$2.8M
Cholinergic Signaling in the BrainR21DA019453 · NIDA · UNIVERSITY OF COLORADO DENVER · PI VIJAYARAGHAVAN, SUKUMAR · 2005 to 2006
$272k
NIDA NIH HHS R01 DA010266NIDA NIH HHS R21 DA019453NIDCD NIH HHS R01 DC008855
6 · The paper itself

Abstract

Nicotine, the addictive component of cigarette smoke has profound effects on the brain. Activation of its receptors by nicotine has complex consequences for network activity throughout the brain, potentially contributing to the addictive property of the drug. Nicotinic receptors have been implicated in psychiatric illnesses like schizophrenia and are also neuroprotective, potentially beneficial for neurodegenerative diseases. These effects of nicotine serve to emphasize the multifarious roles the drug, acting through multiple nicotinic acetylcholine receptor subtypes. The findings also remind us of the complexity of signaling mechanisms and stress the risks of unintended consequences of drugs designed to combat nicotine addiction.

Identifiers

PMID20148179
PMCPMC2817963
OpenAlexW4211266920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.